Addition of Everolimus Post VEGFR Inhibition Treatment Failure in Advanced Sarcoma Patients Who Previously Benefited from VEGFR Inhibition: A Case Series

• Adam C. ElNaggar,

  Affiliation Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio, United States of America

  http://orcid.org/0000-0003-3409-583X

  ⨯
• John L. Hays,

  Affiliations Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio, United States of America, Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• James L. Chen

  * E-mail: James.Chen@osumc.edu

  Affiliations Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States of America, Division of Bioinformatics, Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, United States of America

  ⨯